Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6a03166b3678f86a626aca60",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glycopyrrolate formoterol fumarate and budesonide inhalation",
"description": "Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nWhen patients and healthcare providers search for a reliable inhalation therapy for chronic respiratory conditions, Glycopyrrolate + Formoterol Fumarate + Budesonide inhalation stands out as a modern triple-combination treatment designed to support long-term breathing management. This combination is commonly prescribed in patients requiring advanced maintenance therapy for chronic airway obstruction and inflammation.\nThe three active ingredients work together to help open the airways, reduce inflammation, and improve overall lung function. Triple-combination inhalation therapy is widely used in chronic respiratory management and is commonly prescribed for adults needing long-term control of airway symptoms. \nWhat is Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation?\nThis inhalation contains three clinically proven medicines:\n1. Glycopyrrolate\nGlycopyrrolate helps relax airway muscles by blocking muscarinic receptors. This action keeps air passages open for easier breathing.\n2. Formoterol Fumarate\nFormoterol is a long-acting bronchodilator that helps maintain airway relaxation for extended periods.\n3. Budesonide\nBudesonide reduces airway inflammation, swelling, and irritation, helping lower flare-ups in chronic respiratory disease.\nTogether, these three medicines create a comprehensive treatment option for respiratory maintenance therapy. \nKey Buyer Benefits of This Inhalation\nHealthcare professionals and procurement teams often choose this inhalation because of its multiple benefits:\nSuperior Triple Action\nInstead of prescribing multiple inhalers, this triple combination provides three therapeutic actions in one inhalation device.\nImproved Lung Function\nPatients may experience better airflow and improved breathing comfort with regular prescribed use.\nReduced Respiratory Flare-Ups\nClinical use shows that triple therapy can help reduce worsening episodes in chronic airway disease. \nBetter Patient Compliance\nA single inhaler may improve convenience and adherence to treatment plans.\nCommon Uses of Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation\nThis inhalation is commonly prescribed for:\n\n\nChronic Obstructive Pulmonary Disease (COPD)\n\n\nChronic bronchitis\n\n\nAirflow limitation disorders\n\n\nLong-term respiratory maintenance therapy\n\n\nPhysician-directed asthma maintenance in appropriate patients\n\n\nThis medicine is for maintenance treatment and is not intended for immediate relief of sudden breathing attacks. \nHow Does This Triple Combination Work?\nEach component contributes differently:\nGlycopyrrolate reduces airway tightening.\nFormoterol Fumarate keeps air passages open for longer periods.\nBudesonide controls airway inflammation.\nThis combined mechanism helps support easier breathing and better respiratory stability.\nWhy Buyers Choose This Product\nHospitals, distributors, pharmacies, and healthcare procurement teams often look for products that offer:\n\n\nHigh therapeutic value\n\n\nReliable respiratory support\n\n\nEasy inhalation administration\n\n\nReduced need for multiple inhalers\n\n\nStrong physician acceptance\n\n\nBecause this product combines anti-inflammatory and bronchodilator benefits, it remains a preferred respiratory care option.\nDosage and Administration\nThe exact dosage should always be prescribed by a healthcare professional.\nTypical maintenance inhalation regimens are taken twice daily depending on formulation and clinical need. Patients should rinse their mouth after use to help reduce local side effects. \nImportant Usage Tips\n\n\nShake inhaler before use\n\n\nUse exactly as prescribed\n\n\nDo not exceed recommended doses\n\n\nPrime inhaler if instructed\n\n\nStore in a cool and dry place\n\n\nPossible Side Effects\nLike all prescription medicines, some users may experience side effects such as:\n\n\nDry mouth\n\n\nThroat irritation\n\n\nHoarseness\n\n\nMild cough\n\n\nHeadache\n\n\nOral fungal infection\n\n\nFast heartbeat in some patients\n\n\nMost effects are manageable under medical supervision. \nSafety Precautions\nBefore using this inhalation, patients should inform their doctor if they have:\n\n\nHeart disease\n\n\nHigh blood pressure\n\n\nDiabetes\n\n\nThyroid disorders\n\n\nKidney problems\n\n\nLiver disease\n\n\nGlaucoma\n\n\nPregnant or breastfeeding patients should use it only under medical supervision.\nPackaging and Commercial Availability\nThis product is generally available in metered-dose inhaler packaging suitable for:\n\n\nHospitals\n\n\nMedical distributors\n\n\nExport buyers\n\n\nRetail pharmacies\n\n\nRespiratory specialty clinics\n\n\nBulk procurement options may be available depending on manufacturer and supply chain requirements.\nWhy This Inhalation is a Smart Healthcare Purchase\nFor medical buyers and respiratory specialists, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation offers:\n\n\nTriple mechanism support\n\n\nTrusted respiratory treatment profile\n\n\nStrong prescription demand\n\n\nGrowing market acceptance\n\n\nLong-term patient care utility\n\n\nConclusion\nIf you are searching for an advanced respiratory maintenance solution, Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation delivers comprehensive airway support through bronchodilation and anti-inflammatory action. Whether for hospital procurement, pharmacy distribution, or physician prescribing needs, this triple-combination inhalation remains a high-demand therapeutic option in respiratory medicine.\n",
"price": 885.0,
"discountamount": 266.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2417,
"imageuri": "https://productimages.withfloats.com/actual/6a03166ee67a7c906d87cf8d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a03166ee67a7c906d87cf8d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-12T12:00:43.79Z",
"updatedon": "2026-06-04T07:57:03.191Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glycopyrrolate-formoterol-fumarate-and-budesonide-inhalation/2417",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BUDEPRESS PLUS INH",
"category": "ASTHMARANGE",
"tags": [
"glycopyrrolate formoterol fumarate and budesonide inhalation",
"buy budesonide glycopyrrolate formoterol fumarate",
"budesonide glycopyrrolate formoterol fumarate",
"glycopyrrolate formoterol fumarate",
"Glycopyrrolate Formoterol Fumarate and Budesonide Inhalation",
"Buy Glycopyrrolate Formoterol Budesonide Inhaler Online",
"Triple Combination Inhaler for COPD Treatment",
"Asthma Treatment Inhaler with Budesonide and Formoterol",
"Budesonide Formoterol Glycopyrrolate Inhalation Therapy",
"Prescription Inhaler for COPD and Asthma Management",
"Glycopyrrolate Formoterol Budesonide Inhaler Product Image",
"Best Triple Therapy Inhaler for Breathing Disorders",
"Budesonide Glycopyrrolate Formoterol Inhaler for Lung Care",
"Budesonide, glycopyrrolate, formoterol brand name",
"glycopyrrolate formoterol fumarate and budesonide inhalation in hindi",
"glycopyrrolate formoterol fumarate and budesonide inhalation price",
"glycopyrrolate formoterol fumarate and budesonide inhalation price in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6983339e9e3c03f73212355b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glycopyrrolate 25 formoterol 12 budesonide 400",
"description": "BUDESHINE PLUS 400 is an advanced inhalation therapy offered by Steris Healthcare, specially formulated for individuals suffering from chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It combines three potent active ingredients: Budesonide IP (400 mcg), a corticosteroid that reduces airway inflammation; Glycopyrronium (25 mcg), a long-acting anticholinergic that eases bronchial constriction; and Formoterol Fumarate (12 mcg), a long-acting beta-2 agonist that helps in smooth muscle relaxation of the airways. This triple combination ensures comprehensive symptom management, helping patients breathe easier and maintain an active lifestyle.\n\nUses\n\nBUDESHINE PLUS 400 is primarily used for:\n\nManaging and controlling moderate to severe asthma.\n\nTreatment of chronic obstructive pulmonary disease (COPD) to reduce flare-ups.\n\nRelieving wheezing, shortness of breath, and chest tightness associated with airway inflammation.\n\nProviding maintenance therapy for patients requiring long-term control of respiratory symptoms.\n\nBy targeting different pathways of airway obstruction, this combination offers both immediate relief and long-term control of chronic respiratory conditions.\n\nBenefits\n\nThe unique combination of Budesonide, Glycopyrronium, and Formoterol Fumarate in BUDESHINE PLUS 400 provides multiple benefits:\n\nReduces Inflammation: Budesonide helps calm swelling and irritation in the airways, minimizing asthma attacks.\n\nOpens Airways Effectively: Glycopyrronium relaxes the bronchial muscles, enhancing airflow and reducing breathlessness.\n\nLong-Lasting Relief: Formoterol Fumarate ensures sustained bronchodilation, improving lung function for up to 12 hours.\n\nImproved Quality of Life: Regular use helps patients maintain daily activities with fewer respiratory interruptions.\n\nDual Action for Exacerbations: Reduces the frequency and severity of asthma or COPD flare-ups.\n\nDosage\n\nThe dosage of BUDESHINE PLUS 400 should be strictly followed as prescribed by a healthcare professional. Typical guidance includes:\n\nAdults and adolescents (12 years and above): 1–2 inhalations twice daily.\n\nUsage: Shake the inhaler well before each use. Exhale fully, place the mouthpiece in the mouth, and inhale slowly while pressing the canister. Hold the breath for 5–10 seconds for maximum efficacy.\n\nMaintenance: Consistency is key—use the inhaler regularly for optimal long-term benefits.\n\nPatients should avoid exceeding the prescribed dose and consult their doctor before adjusting frequency.\n\nSide Effects\n\nWhile BUDESHINE PLUS 400 is generally well-tolerated, some users may experience:\n\nMild throat irritation or hoarseness\n\nDry mouth\n\nOccasional coughing or nasal congestion\n\nRarely, headache, tremors, or palpitations due to Formoterol\n\nFungal infections in the mouth (oral thrush) from corticosteroid use\n\nMost side effects are manageable and can be minimized by rinsing the mouth after inhalation and following proper inhaler techniques.\n\nPrecautions and Warning\n\nBefore using BUDESHINE PLUS 400, consider the following precautions:\n\nInform your doctor if you have heart problems, glaucoma, diabetes, or kidney/liver conditions.\n\nAvoid use during acute asthma attacks; seek immediate medical help instead.\n\nPregnant or breastfeeding women should consult a healthcare provider before use.\n\nDo not stop or change dosage abruptly without medical advice, as it may worsen respiratory symptoms.\n\nStore in a cool, dry place and keep away from direct sunlight or heat sources.\n\nConclusion\n\nBUDESHINE PLUS 400 is a powerful and reliable inhalation therapy that combines anti-inflammatory, bronchodilator, and anticholinergic effects for comprehensive respiratory care. With consistent use, it helps manage asthma and COPD effectively, reduces exacerbations, and improves overall lung function. Trusted by healthcare professionals and manufactured under strict quality standards by Steris Healthcare, BUDESHINE PLUS 400 offers a balanced solution for long-term respiratory wellness.",
"price": 520.0,
"discountamount": 156.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2292,
"imageuri": "https://productimages.withfloats.com/actual/698333a014605fdee7544bd7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/698333a014605fdee7544bd7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-04T11:55:10.524Z",
"updatedon": "2026-03-14T07:24:46.522Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glycopyrrolate-25-formoterol-12-budesonide-400/2292",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BUDESHINE PLUS 400",
"category": "ASTHMARANGE",
"tags": [
"Budesonide IP 400 mcg",
"Glycopyrronium 25 mcg",
"Formoterol Fumarate 12 mcg",
"muscle relaxation of the airways",
"glycopyrrolate formoterol budesonide 400 inhaler",
"glycopyrrolate 25 formoterol 12 budesonide 400",
"budesonide glycopyrrolate formoterol inhaler",
"triple combination inhaler budesonide",
"glycopyrrolate budesonide formoterol combo",
"glycopyrrolate 25 mcg formoterol 12 mcg inhaler",
"budesonide 400 mcg triple therapy inhaler",
"triple inhaler 400 mcg budesonide",
"budesonide 400 glycopyrrolate combo inhaler",
"triple therapy inhaler for severe asthma",
"glycopyrrolate formoterol inhaler uses",
"glycopyrrolate formoterol budesonide inhaler uses",
"glycopyrrolate formoterol budesonide side effects",
"glycopyrrolate formoterol budesonide dosage",
"triple therapy inhaler how to use",
"budesonide triple inhaler benefits",
"glycopyrrolate formoterol budesonide inhaler price",
"glycopyrrolate budesonide inhaler manufacturer",
"best glycopyrrolate formoterol budesonide inhaler",
"glycopyrrolate 25 formoterol 12 budesonide inhaler",
"triple inhaler for copd with budesonide"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6863d70eaf0c9d1aa0c2d3e5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "fluticasone furoate and vilanterol powder for inhalation",
"description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.",
"price": 740.0,
"discountamount": 222.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"12 years",
"24 hours",
"increased risk",
"drugs interact",
"antiviral medications",
"recommended dose",
"airways open",
"reduce inflammation",
"acute asthma",
"asthma attacks",
"severe asthma",
"copd attacks",
"inhaler consistently",
"optimal results",
"breathing comfort",
"longacting bronchodilation",
"antiinflammatory power",
"inhaled corticosteroids",
"vilanterol antifungal",
"tricyclic antidepressants",
"taking betablockers",
"prescribed inform",
"tuberculosis rinse",
"headache hoarseness",
"initial phase",
"generally welltolerated",
"fluticatone vilo 200",
"exercise capacity",
"emphysema reduces",
"chronic bronchitis",
"relaxing muscles",
"rescue medicine",
"vilanterol relaxes",
"prevent symptoms",
"specially formulated",
"vilanterol 25 mcg",
"vilanterol powder",
"rare effects",
"ketoconazole ritonavir",
"healthcare provider",
"therapy common",
"potent corticosteroid",
"fluticasone furoate",
"side effects",
"lung function",
"vilanterol fluticasone furoate",
"copd exacerbations improves",
"inhalation fluticasone furoate",
"lung function quality",
"fixeddose inhalation powder",
"increase corticosteroid levels",
"fastacting inhaler inform",
"combination inhalation therapy",
"side effects consult",
"frequent side effects",
"inhalation longterm treatment",
"healthcare providers guidance",
"ritonavir itraconazole leading",
"highly effective corticosteroid",
"effective oncedaily treatment",
"heart rhythm disturbances",
"strong cyp3a4 inhibitors",
"hypokalemia mao inhibitors",
"atenolol propranolol diuretics",
"breastfeeding drug interactions",
"pregnant planning pregnancy",
"avoid oral thrush",
"sore throat cough",
"adolescents maintenance treatment",
"longterm maintenance treatment",
"prescription combination medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2140,
"imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png",
"tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:39:42.59Z",
"updatedon": "2026-03-14T08:43:22.38Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//fluticasone-furoate-and-vilanterol-powder-for-inhalation/2140",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "FLUTICATONE VILO 200",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation",
"chronic obstructive pulmonary disease",
"lung function",
"Fluticasone Furoate and Vilanterol Powder",
"emphysema."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6863d2854c1970de3d96ebcd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "fluticasone furoate and vilanterol powder for inhalation",
"description": "FLUTICATONE VILO 100 is a combination inhalation therapy designed to manage and control chronic respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This formulation contains two powerful agents: Fluticasone Furoate (100 mcg), a corticosteroid that reduces inflammation in the airways, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA) that helps in bronchodilation by relaxing airway muscles. Together, they provide long-term relief from symptoms like wheezing, shortness of breath, and chest tightness.\n\nThis powder is administered via inhalation, allowing targeted action directly at the site of inflammation and constriction, making it an effective and fast-acting treatment choice for those suffering from persistent asthma or airflow obstruction in COPD.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription medication used for long-term maintenance treatment of asthma and COPD in adults and adolescents. Fluticasone furoate is a synthetic corticosteroid that controls inflammation and swelling in the lungs. Vilanterol is a bronchodilator that improves breathing by relaxing muscles around the airways. The combination is not intended for acute bronchospasm relief but is ideal for daily use to manage chronic symptoms and prevent flare-ups.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term control of asthma symptoms such as wheezing, coughing, and breathlessness\n\nMaintenance treatment of COPD, including chronic bronchitis and emphysema\n\nPrevention of asthma exacerbations and hospitalizations\n\nImprovement in lung function and quality of life in chronic respiratory patients\n\nRegular use of this inhaler can help reduce dependency on rescue inhalers and lower the frequency of asthma attacks or COPD exacerbations.\n\nFluticasone Furoate and Vilanterol Powder for Inhalation Side Effects\nWhile generally well-tolerated, some users may experience mild to moderate side effects including:\n\nHeadache\n\nThroat irritation\n\nHoarseness of voice\n\nOral thrush (fungal infection in the mouth)\n\nCough or upper respiratory tract infections\n\nIncreased heart rate or palpitations\n\nMuscle cramps or tremors\n\nRare allergic reactions like rash, itching, or swelling\n\nTo minimize the risk of oral thrush, it is advised to rinse the mouth thoroughly after each inhalation.\n\nPrecautions Before Using FLUTICATONE VILO 100\nDo not use it to treat sudden asthma attacks; it is not a rescue inhaler.\n\nInform your doctor if you have a history of heart disease, high blood pressure, diabetes, or liver problems.\n\nUse with caution in pregnancy and breastfeeding; consult your physician.\n\nRegular monitoring of lung function and adrenal activity is recommended during long-term use.\n\nChildren and adolescents may require special dose adjustments under medical supervision.\n\nDrug Interactions: What Drugs Interact with Fluticasone Furoate and Vilanterol?\nSeveral medications may interact with this combination and alter its effectiveness or increase the risk of side effects:\n\nBeta-blockers (e.g., propranolol): May reduce the bronchodilatory effect of vilanterol\n\nKetoconazole or Ritonavir: These strong CYP3A4 inhibitors can increase the levels of fluticasone in the blood, raising the risk of side effects\n\nDiuretics: May increase the risk of hypokalemia when used with vilanterol\n\nOther corticosteroids: Concurrent use may enhance systemic corticosteroid side effects\n\nMAO inhibitors and Tricyclic Antidepressants: May amplify cardiovascular effects\n\nAlways inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting FLUTICATONE VILO 100.\n\nConclusion\nFLUTICATONE VILO 100 is a scientifically advanced, dual-action inhalation therapy that provides effective long-term control for asthma and COPD. With the anti-inflammatory strength of fluticasone furoate 100 mcg and the bronchodilating effect of vilanterol 25 mcg, this combination ensures better breathing, fewer flare-ups, and improved quality of life. It’s a reliable and essential component in the chronic respiratory care of patients who need consistent symptom control and lung function improvement.",
"price": 525.0,
"discountamount": 158.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"combination ensures",
"improved quality",
"medications supplements",
"drugs interact",
"mouth cough",
"reduce dependency",
"synthetic corticosteroid",
"asthma attacks",
"asthma exacerbations",
"asthma symptoms",
"persistent asthma",
"vilanterol powder",
"controls inflammation",
"reduces inflammation",
"vilanterol ketoconazole",
"lungs vilanterol",
"vilanterol 25 mcg",
"essential component",
"bronchodilating effect",
"antiinflammatory strength",
"herbal products",
"healthcare provider",
"tricyclic antidepressants",
"corticosteroids concurrent",
"blood raising",
"bronchodilatory effect",
"adrenal activity",
"breastfeeding consult",
"liver problems",
"fluticatone vilo 100",
"oral thrush",
"rash itching",
"experience mild",
"generally welltolerated",
"emphysema prevention",
"wheezing coughing",
"prescription medication",
"airflow obstruction",
"constriction making",
"chest tightness",
"wheezing shortness",
"inhalation precautions",
"rescue inhalers",
"hospitalizations improvement",
"prevent flareups",
"improves breathing",
"fluticasone furoate",
"chronic bronchitis",
"lung function",
"relaxing muscles",
"rescue inhaler inform",
"adolescents fluticasone furoate",
"manage chronic symptoms",
"inhalation fluticasone furoate",
"lung function improvement",
"effective longterm control",
"breathing fewer flareups",
"inhalation longterm control",
"relaxing airway muscles",
"inhalation side effects",
"longterm maintenance treatment",
"provide longterm relief",
"chronic respiratory care",
"consistent symptom control",
"amplify cardiovascular effects",
"side effects diuretics",
"strong cyp3a4 inhibitors",
"side effects betablockers",
"physician regular monitoring",
"palpitations muscle cramps",
"moderate side effects",
"breathlessness maintenance treatment",
"acute bronchospasm relief",
"fastacting treatment choice"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2139,
"imageuri": "https://productimages.withfloats.com/actual/6863d28eeb66715cb5e18de8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6863d28eeb66715cb5e18de8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:20:21.253Z",
"updatedon": "2026-03-14T08:43:27.599Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//fluticasone-furoate-and-vilanterol-powder-for-inhalation/2139",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "FLUTICATONE VILO 100",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation",
"Chronic Obstructive Pulmonary Disease (COPD).",
"relaxing airway muscles.",
"shortness of breath.",
"chest tightness.",
"lung function improvement."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6a460bf90c11f3c74a816c87",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "methylprednisolone sodium succinate for injection usp",
"description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.",
"price": 47.0,
"discountamount": 19.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2465,
"imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-02T06:58:01.631Z",
"updatedon": "2026-07-02T06:58:01.631Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//methylprednisolone-sodium-succinate-for-injection-usp/2465",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METHIDENOSOLE 40 INJ",
"category": "GENERAL RANGE",
"tags": [
"methylprednisolone sodium succinate injection uses",
"methylprednisolone sodium succinate injection uses in hindi",
"methylprednisolone sodium succinate",
"methylprednisolone sodium succinate injection",
"inj methylprednisolone sodium succinate",
"methylprednisolone sodium succinate uses in hindi",
"methylprednisolone sodium succinate for injection",
"methylprednisolone sodium succinate injection usp"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69942f823b20a66d9dcf9458",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder",
"description": "GLYCOPRESS INDUS™ is a modern dual bronchodilator therapy formulated with Indacaterol Maleate and Glycopyrronium Bromide, designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This advanced inhalation formulation combines two complementary mechanisms of action to deliver sustained airway relaxation, improved lung function, and enhanced breathing comfort.\n\nCOPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and episodes of breathlessness. Effective management requires consistent bronchodilation to keep the airways open and reduce daily symptoms. GLYCOPRESS INDUS™ addresses this need through a once-daily maintenance approach that targets airway narrowing through dual pharmacological pathways.\n\nManufactured under strict quality standards, GLYCOPRESS INDUS™ ensures reliable dosing, stability, and optimal pulmonary delivery when used with the recommended inhalation device. It is intended for regular use and not for the treatment of sudden breathing emergencies.\n\nComposition and Mechanism of Action\n\nGLYCOPRESS INDUS™ combines two long-acting bronchodilators:\n\n1. Indacaterol Maleate (Long-Acting Beta2-Agonist – LABA)\n\nIndacaterol stimulates beta2-adrenergic receptors located in the smooth muscles of the airways. Activation of these receptors causes the muscles to relax, resulting in bronchodilation. This effect:\n\nReduces airway resistance\n\nImproves airflow\n\nDecreases breathlessness\n\nSupports 24-hour bronchodilation\n\nIndacaterol is known for its rapid onset and prolonged duration of action, making it effective for once-daily therapy.\n\n2. Glycopyrronium Bromide (Long-Acting Muscarinic Antagonist – LAMA)\n\nGlycopyrronium blocks muscarinic receptors in the bronchial smooth muscles. These receptors normally respond to acetylcholine, which causes airway constriction. By inhibiting this response, glycopyrronium:\n\nPrevents bronchospasm\n\nReduces airway tightening\n\nPromotes sustained airway relaxation\n\nDual-Action Advantage\n\nThe combination of LABA and LAMA in GLYCOPRESS INDUS™ provides enhanced bronchodilation compared to either agent alone. While indacaterol actively relaxes airway muscles, glycopyrronium prevents them from tightening. This complementary action ensures comprehensive and sustained airway management.\n\nIndications and Uses\n\nGLYCOPRESS INDUS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nChronic bronchitis management\n\nEmphysema management\n\nLong-term airflow limitation therapy\n\nIt is important to understand that GLYCOPRESS INDUS™:\n\nIs not a rescue inhaler\n\nShould not be used for sudden acute bronchospasm\n\nIs not intended for primary asthma treatment unless prescribed by a physician\n\nPatients should always keep a short-acting bronchodilator available for emergency relief.\n\nKey Benefits of GLYCOPRESS INDUS™\n1. Once-Daily Dosing Convenience\n\nGLYCOPRESS INDUS™ is formulated for once-daily administration, improving adherence and simplifying treatment routines.\n\n2. Dual Bronchodilation for Superior Airway Control\n\nThe LABA + LAMA combination provides broader and more effective airway relaxation compared to single-agent therapy.\n\n3. Rapid Onset with Sustained Effect\n\nIndacaterol provides quick bronchodilation, while glycopyrronium maintains airway openness for up to 24 hours.\n\n4. Improved Lung Function\n\nRegular use can enhance lung performance parameters, such as improved airflow measurements and reduced air trapping.\n\n5. Reduced Breathlessness\n\nPatients may experience decreased shortness of breath during physical activities, leading to greater independence.\n\n6. Lower Frequency of COPD Exacerbations\n\nConsistent airway maintenance can help reduce the likelihood of flare-ups and hospital visits.\n\n7. Enhanced Quality of Life\n\nBetter breathing control contributes to improved sleep, increased exercise tolerance, and overall well-being.\n\nDosage and Administration\n\nGLYCOPRESS INDUS™ should be used exactly as prescribed by a healthcare professional.\n\nGeneral Administration Guidelines:\n\nUse once daily at the same time each day.\n\nInhale using the provided inhalation device.\n\nDo not swallow capsules (if capsule-based system).\n\nDo not exceed the recommended dose.\n\nFollow inhaler technique instructions carefully.\n\nProper inhalation technique is essential for effective drug delivery. Healthcare providers should demonstrate correct usage during initial prescription.\n\nPossible Side Effects\n\nWhile GLYCOPRESS INDUS™ is generally well tolerated, some individuals may experience side effects.\n\nCommon Side Effects\n\nDry mouth\n\nCough\n\nThroat irritation\n\nHeadache\n\nNasal congestion\n\nMild tremor\n\nDizziness\n\nThese symptoms are often mild and may diminish with continued use.\n\nCardiovascular Effects\n\nDue to the beta2-agonist component (indacaterol), some patients may experience:\n\nIncreased heart rate\n\nPalpitations\n\nMild fluctuations in blood pressure\n\nPatients with pre-existing heart conditions should consult their physician before starting therapy.\n\nAnticholinergic Effects (from Glycopyrronium)\n\nDifficulty urinating\n\nBlurred vision\n\nWorsening of narrow-angle glaucoma\n\nIndividuals with urinary retention or glaucoma should use caution.\n\nRare but Serious Reactions\n\nParadoxical bronchospasm (worsening breathing immediately after inhalation)\n\nSevere allergic reactions\n\nSignificant cardiac rhythm disturbances\n\nImmediate medical attention should be sought if severe reactions occur.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS INDUS™, inform your healthcare provider if you have:\n\nCardiovascular disease\n\nArrhythmias\n\nHypertension\n\nHyperthyroidism\n\nDiabetes\n\nSeizure disorders\n\nGlaucoma\n\nProstate enlargement\n\nKidney impairment\n\nDrug Interactions\n\nCaution is required when using:\n\nOther long-acting beta2-agonists\n\nOther anticholinergic medications\n\nBeta-blockers\n\nDiuretics\n\nCertain antidepressants (e.g., MAO inhibitors)\n\nAlways provide a complete list of medications and supplements to your healthcare provider.\n\nWho Should Use GLYCOPRESS INDUS™?\n\nGLYCOPRESS INDUS™ is ideal for:\n\nAdults with moderate to severe COPD\n\nPatients not adequately controlled on single bronchodilator therapy\n\nIndividuals seeking a once-daily maintenance inhaler\n\nPatients requiring dual bronchodilation for improved symptom control\n\nIt is not typically recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nIntegrating GLYCOPRESS INDUS™ into COPD Management\n\nFor optimal results, GLYCOPRESS INDUS™ should be part of a comprehensive COPD management plan that includes:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular physical activity\n\nBalanced nutrition\n\nScheduled medical follow-ups\n\nAdherence to therapy and routine monitoring significantly improve long-term outcomes.\n\nStorage Instructions\n\nStore at room temperature\n\nProtect from moisture and direct sunlight\n\nKeep in original packaging until use\n\nKeep out of reach of children\nConclusion\nGLYCOPRESS INDUS™ (Indacaterol Maleate + Glycopyrronium Bromide) is a powerful dual bronchodilator designed to provide sustained airway control in individuals living with chronic obstructive pulmonary disease. By combining a long-acting beta2-agonist and a long-acting muscarinic antagonist, it offers comprehensive bronchodilation through two complementary pathways.",
"price": 703.0,
"discountamount": 211.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2308,
"imageuri": "https://productimages.withfloats.com/actual/69942f8410196f5f212c916f.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69942f8410196f5f212c916f.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-17T09:06:10.4Z",
"updatedon": "2026-04-08T08:59:59.008Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//fdc-of-indacaterol-maleate-and-glycopyrronium-bromide-inhalation-powder/2308",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLYCOPRESS INDUS",
"category": "ASTHMARANGE",
"tags": [
"indacaterol maleate",
"fdc of indacaterol maleate uses",
"fdc of indacaterol maleate uses in hindi",
"fdc of indacaterol maleate and glycopyrronium bromide inhalation powder",
"indacaterol maleate and glycopyrronium bromide",
"indacaterol maleate glycopyrronium bromide price",
"fdc of indacaterol maleate"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6912fc8c470ec71b0ac87646",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "mometasone furoate formoterol fumarate inhaler",
"description": "Mometasone Furoate and Formoterol Fumarate Inhaler is a combination respiratory medication formulated to provide effective and long-lasting control of asthma and chronic obstructive pulmonary disease (COPD). It combines two powerful active ingredients — Mometasone Furoate, a corticosteroid (anti-inflammatory), and Formoterol Fumarate, a long-acting bronchodilator (LABA). Together, these components help patients breathe easier by reducing airway inflammation and relaxing the muscles of the airways.\n\nThis dual-action inhaler is designed for maintenance therapy rather than immediate relief of acute symptoms. By targeting both inflammation and bronchial constriction, it provides a comprehensive approach to long-term respiratory management. Each inhalation delivers a precise dose to ensure consistent therapeutic results and improved lung function.\n\nMometasone Furoate and Formoterol Fumarate Inhaler is ideal for individuals who experience persistent asthma symptoms or airflow obstruction due to COPD, despite using single-ingredient inhalers.\n\nUses and Therapeutic Indications\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler is prescribed for the following respiratory conditions:\n\nAsthma (Bronchial Asthma):\n\nUsed for the long-term control and prevention of symptoms such as wheezing, breathlessness, and chest tightness.\n\nHelps reduce inflammation and airway hyperreactivity to prevent asthma attacks.\n\nChronic Obstructive Pulmonary Disease (COPD):\n\nHelps manage chronic bronchitis and emphysema by improving airflow and reducing airway inflammation.\n\nMaintenance Therapy:\n\nProvides ongoing treatment for patients whose symptoms are not adequately controlled by inhaled corticosteroids or bronchodilators alone.\n\nThis inhaler is not meant for emergency relief during sudden asthma attacks but rather as a daily maintenance therapy to control symptoms and prevent exacerbations.\n\nKey Benefits\n\nDual Mechanism of Action:\nCombines the anti-inflammatory power of Mometasone Furoate with the bronchodilating action of Formoterol Fumarate, offering complete respiratory control in one inhaler.\n\nReduces Airway Inflammation:\nMometasone Furoate suppresses the body’s inflammatory response, helping reduce swelling, mucus buildup, and irritation in the airways.\n\nLong-Lasting Bronchodilation:\nFormoterol provides fast and sustained relaxation of airway muscles, improving airflow and making breathing easier for up to 12 hours.\n\nImproves Lung Function:\nRegular use enhances pulmonary capacity, allowing patients to perform daily activities without breathing difficulty.\n\nFewer Asthma Exacerbations:\nReduces the frequency and severity of asthma attacks and flare-ups associated with COPD.\n\nConvenient Combination Therapy:\nProvides the benefits of two medications in a single device, improving compliance and simplifying treatment routines.\n\nBetter Symptom Control:\nProven to decrease wheezing, coughing, and nighttime symptoms, leading to better sleep and overall quality of life.\n\nRapid Onset of Action:\nFormoterol acts within minutes to ease breathing while Mometasone works continuously to maintain long-term inflammation control.\n\nPossible Side Effects\n\nWhile the Mometasone Furoate and Formoterol Fumarate Inhaler is well tolerated, some individuals may experience mild to moderate side effects, especially during the early phase of therapy. These include:\n\nThroat Irritation or Dryness\n\nHoarseness or Voice Changes\n\nHeadache or Dizziness\n\nCough or Upper Respiratory Tract Infections\n\nMuscle Cramps or Tremors\n\nPalpitations (Fast or Irregular Heartbeat)\n\nNausea or Mild Stomach Upset\n\nOral Thrush (Fungal Infection in the Mouth or Throat) – often preventable by rinsing the mouth with water after inhalation.\n\nPrecautions:\n\nThis inhaler is not a rescue medication; a short-acting bronchodilator should be kept on hand for sudden breathing attacks.\n\nRegular use is essential for best results — do not stop suddenly without consulting a doctor.\n\nPatients with heart conditions, hypertension, thyroid disorders, diabetes, or osteoporosis should use this medicine under medical supervision.\n\nAlways rinse the mouth after use to prevent fungal infections.\n\nConclusion\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler represents a modern, evidence-based approach to managing chronic respiratory conditions such as asthma and COPD. By combining a corticosteroid (to reduce airway inflammation) with a long-acting bronchodilator (to open the airways), it provides effective, dual-action relief that lasts throughout the day.\n\nRegular use of this inhaler helps improve breathing capacity, reduces symptom frequency, and enhances quality of life for individuals struggling with chronic lung diseases. It not only helps patients achieve better control over their respiratory symptoms but also reduces the need for emergency interventions and hospitalizations.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2199,
"imageuri": "https://productimages.withfloats.com/actual/6912fc8e6447ec42b9808956.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6912fc8e6447ec42b9808956.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-11T09:06:20.511Z",
"updatedon": "2026-03-14T08:49:38.354Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mometasone-furoate-formoterol-fumarate-inhaler/2199",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MONTASENSE F INH",
"category": "ASTHMA RANGE",
"tags": [
"Mometasone Furoate and Formoterol Fumarate Inhaler",
"respiratory medication",
"chronic obstructive pulmonary disease (COPD)",
"muscles of the airways.",
"respiratory control in one inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler for asthma treatment",
"Mometasone Furoate Formoterol Fumarate dosage guide",
"Mometasone Furoate Formoterol Fumarate inhaler side effects",
"Best time to use Mometasone Furoate Formoterol Fumarate inhaler",
"Buy Mometasone Furoate Formoterol Fumarate inhaler online",
"Mometasone Furoate Formoterol Fumarate inhaler price per unit",
"Where to purchase Mometasone Furoate Formoterol Fumarate inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler buy at the best price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "690b41bfb84ade1a1a5cf07f",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tiotropium Bromide and Formoterol Fumarate Inhaler",
"description": "Tiotropium Bromide and Formoterol Fumarate Inhaler is a combination medication designed to provide long-term relief for patients suffering from chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This inhaler combines the bronchodilator properties of tiotropium bromide with the fast-acting benefits of formoterol fumarate, ensuring both immediate and sustained relief from breathing difficulties. By improving airflow in the lungs, this inhaler significantly enhances the quality of life for individuals with obstructive airway diseases.\n\nComposition and Mechanism of Action\nThe inhaler contains two active ingredients:\n\nTiotropium Bromide – a long-acting anticholinergic agent that relaxes the muscles around the airways, preventing bronchospasm and helping to keep the airways open for an extended period.\n\nFormoterol Fumarate – a long-acting beta-2 adrenergic agonist (LABA) that quickly relaxes airway muscles, providing fast relief from shortness of breath and wheezing.\n\nTogether, these agents work synergistically. Tiotropium ensures long-term bronchodilation, while formoterol provides rapid symptom relief, making this inhaler ideal for patients who require both immediate and sustained respiratory support.\n\nUses\nThe Tiotropium Bromide and Formoterol Fumarate Inhaler is primarily used to:\n\nManage Chronic Obstructive Pulmonary Disease (COPD) – Helps reduce the frequency and severity of COPD exacerbations, improving breathing efficiency.\n\nControl Asthma Symptoms – Offers better control of persistent asthma symptoms, particularly in patients who do not respond adequately to standard inhalers.\n\nPrevent Exercise-Induced Bronchospasm – Can be used as part of a preventive regimen for patients prone to exercise-triggered breathing difficulties.\n\nEnhance Overall Lung Function – Improves airflow and oxygen exchange, contributing to better overall respiratory health.\n\nDosage and Administration\nProper usage of the inhaler is critical for maximum effectiveness. The dosage may vary based on your condition and doctor's recommendation. General guidelines include:\n\nTypically, one inhalation twice daily (morning and evening).\n\nShake the inhaler well before each use.\n\nExhale fully, place the mouthpiece in your mouth, and inhale deeply while pressing the inhaler to release the medication.\n\nHold your breath for 10 seconds after inhalation to ensure the medication reaches deep into the lungs.\n\nRinse your mouth with water after use to reduce the risk of oral infections or irritation.\n\nPatients should strictly follow their doctor’s instructions regarding dosage, frequency, and technique, as incorrect use may reduce the medication’s effectiveness.\n\nKey Benefits\n\nDual Action for Immediate and Long-Term Relief – Combines a fast-acting bronchodilator with a long-acting maintenance agent.\n\nReduces Exacerbations – Regular use can significantly lower the risk of flare-ups and hospital visits for COPD or severe asthma patients.\n\nImproves Lung Function – Enhances airflow and oxygen intake, leading to reduced shortness of breath and wheezing.\n\nConvenient Usage – A single inhaler provides both maintenance and symptom relief, reducing the need for multiple medications.\n\nEnhanced Quality of Life – Patients often experience better sleep, increased physical activity tolerance, and improved daily functioning.\n\nSide Effects\nWhile Tiotropium Bromide and Formoterol Fumarate Inhaler is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nDry mouth or throat irritation\n\nCough or hoarseness\n\nHeadache or dizziness\n\nTremors or mild palpitations\n\nSerious but rare side effects may include:\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nIrregular heartbeat or chest pain\n\nWorsening of respiratory symptoms\n\nPatients should immediately consult a healthcare professional if they experience severe or persistent side effects. Regular follow-up with a doctor is recommended to monitor lung function and adjust the dosage if necessary.\n\nPrecautions\n\nNot recommended for individuals with hypersensitivity to either tiotropium bromide or formoterol fumarate.\n\nShould be used cautiously in patients with cardiovascular diseases, kidney or liver problems, or thyroid disorders.\n\nAvoid sudden discontinuation without consulting your doctor, as this may worsen symptoms.\n\nAlways carry a rescue inhaler for emergency situations, as this inhaler is primarily for maintenance and not for immediate acute attacks.\n\nPrice\nThe price of Tiotropium Bromide and Formoterol Fumarate Inhaler may vary depending on the brand, pack size, and pharmacy. It is advisable to compare prices and check with local pharmacies for the most cost-effective options. Many insurance plans may cover this inhaler under prescription respiratory medications.\n\nConclusion\nTiotropium Bromide and Formoterol Fumarate Inhaler is a highly effective combination treatment for patients suffering from COPD and asthma. By providing both rapid symptom relief and long-term airway maintenance, it helps patients breathe more easily, reduces the frequency of exacerbations, and improves overall quality of life. Proper usage, adherence to prescribed dosage, and monitoring for side effects are essential for achieving the best results. For anyone managing chronic respiratory conditions, this inhaler represents a reliable and convenient treatment option under medical guidance.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2196,
"imageuri": "https://productimages.withfloats.com/actual/690b41c1d25e5639c9089541.png",
"tileimageuri": "https://productimages.withfloats.com/tile/690b41c1d25e5639c9089541.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-05T12:23:27.485Z",
"updatedon": "2026-03-14T08:50:22.16Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tiotropium-bromide-and-formoterol-fumarate-inhaler/2196",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TIOTROPIN F",
"category": "ASTHMA RANGE",
"tags": [
"Tiotropium Bromide and Formoterol Fumarate Inhaler",
"Chronic Obstructive Pulmonary Disease (COPD) and asthma.",
"Chronic Obstructive Pulmonary Disease (COPD) and asthma"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}